Cancer

Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders

Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference

How Growing Number of Industries are Leveraging Artificial Intelligence to Create Lucrative Revenue Opportunities

FN Media Group News Commentary  PALM BEACH, Fla., Jan. 17, 2025 /PRNewswire/ -- The healthcare industry is rapidly integrating artificial intelligence (AI)-powered solutions...

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Design lock for ASIC microchip follows successful completion of in vivo preclinical and extensive bench testing Manufacturing of ASIC microchip...

Medical Gas Blenders Market size to increase by USD 582 Million between 2023 to 2028, Market Segmentation by End-user, Product, Geography, Technavio

NEW YORK, Jan. 17, 2025 /PRNewswire/ -- The global medical gas blenders market size is estimated to grow by USD 582...

Analytical Standards Market size to increase by USD 657.8 Million between 2023 to 2028, Market Segmentation by Type, Application, Geography, Methodology , Technavio

NEW YORK, Jan. 17, 2025 /PRNewswire/ -- The global analytical standards market size is estimated to grow by USD 657.8 million...

GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors

– Financing Led by Evidity Health Capital –  TEMPE, Ariz., Jan. 16, 2025 /PRNewswire/ -- GT Medical Technologies, Inc. (GT...

error: Content is protected !!